Global Meningitis Vaccine Market Size, by Diseases Type (Viral, Bacterial, Pneumococcal Meningitis), by Vaccines (Polysaccharide, Conjugate Vaccines, Combination Vaccines), & Region - Key Manufacturers, Analysis, Growth Trends, and Forecast till 2026

  • Category : Healthcare and Pharma
  • |
  • ID : 1012324
  • |
  • Publishe Date : May 2019
  • |
  • No of Pages: 121
  • |
  • Publisher : Intellectual Research Partners

The Global Meningitis Vaccine market was estimated to be valued at USD XX million in 2019 and is projected to reach USD XX million by 2026, at a CAGR of XX% during 2019 to 2026. Increase in awareness about meningitis immunization and high prevalence of bacterial meningitis, are factors augmenting the meningitis vaccine market globally. However, bacterial resistance to penicillin and lack of access to vaccine approval are some of the major factors impeding the growth of the market.

The global meningitis vaccine market is primarily segmented based on different diseases type, vaccines, and regions.

On the basis of diseases type, the market is split into:
* Viral Meningitis
* Bacterial Meningitis
* Meningococcal Disease
* Pneumococcal Meningitis
* Other types of Meningitis

On the basis of vaccines, the market is split into:
* Polysaccharide Vaccines
* Conjugate Vaccines
* Combination Vaccines

Moreover, the market is classified based on regions and countries as follows:
* North America- U.S., Canada
* Europe- U.K., France, Germany, Italy and Rest of Europe
* Asia-Pacific- China, Japan, India and Rest of Asia Pacific
* South America- Brazil, Mexico and Rest of South America
* Middle East & Africa- South Africa, Saudi Arabia and Rest of Middle East & Africa

Key Market Players:
The key players profiled in the market include:
* GlaxoSmithKline
* Baxter International
* Sanofi Pasteur
* Merck
* Pfizer
* Serum Institute of India Pvt. Ltd.
* Panacea Biotec
* Johnson & Johnson
* Astellas Pharma Inc.
* Serum Institute of India Pvt. Ltd.

These enterprises are focusing on growth strategies, such as new product launches, expansions, acquisitions, and agreements & partnerships to expand their operations across the globe.

Key Benefits of the Report:
* Global, regional, country, diseases type, and vaccines market size and their forecast from 2015-2026
* Identification and detailed analysis on key market dynamics, such as, drivers, restraints, opportunities, and challenges influencing growth of the market
* Detailed analysis on industry outlook with market specific PESTLE, and supply chain to better understand the market and build expansion strategies
* Identification of key market players and comprehensively analyze their market share and core competencies, detailed financial positions, key products, and unique selling points
* Analysis on key players’ strategic initiatives and competitive developments, such as joint ventures, mergers, and new product launches in the market
* Expert interviews and their insights on market shift, current and future outlook, and factors impacting vendors’ short term and long term strategies
* Detailed insights on emerging regions, diseases type, and vaccines with qualitative and quantitative information and facts

Target Audience:
* Meningitis Vaccine Manufacturers
* Traders, Importers, and Exporters
* Raw Material Suppliers and Distributors
* Research and Consulting Firms
* Government and Research Organizations
* Associations and Industry Bodies

Research Methodology:
The market is derived through extensive use of secondary, primary, in-house research followed by expert validation and third party perspective, such as, analyst reports of investment banks. The secondary research is the primary base of our study wherein we conducted extensive data mining, referring to verified data sources, such as, white papers, government and regulatory published articles, technical journals, trade magazines, and paid data sources.

For forecasting, regional demand & supply factors, recent investments, market dynamics including technical growth scenario, consumer behavior, and end use trends and dynamics, and production capacity were taken into consideration. Different weightages have been assigned to these parameters and quantified their market impacts using the weighted average analysis to derive the market growth rate.

The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs), which typically include:
* Manufacturers
* Suppliers
* Distributors
* Government Body & Associations
* Research Institutes

TABLE OF CONTENTS

1. Introduction

2. Research Methodology

3. Executive Summary

4. Global Meningitis Vaccine Market Overview
4.1. Market Segmentation & Scope
4.2. Market Trends
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Supply Chain Analysis
4.3. Global Meningitis Vaccine Market - Porter\'s Five Forces Analysis
4.4. Global Meningitis Vaccine Market - PESTEL Analysis

5. Global Meningitis Vaccine Market, by Diseases Type
5.1. Global Meningitis Vaccine Market, Size and Forecast, 2015-2026
5.2. Global Meningitis Vaccine Market, by Viral Meningitis, 2015-2026
5.2.1. Key driving factors, trends and opportunities
5.2.2. Market size and forecast, 2015-2026
5.3. Global Meningitis Vaccine Market, by Bacterial Meningitis, 2015-2026
5.3.1. Key driving factors, trends and opportunities
5.3.2. Market size and forecast, 2015-2026
5.4. Global Meningitis Vaccine Market, by Meningococcal Disease, 2015-2026
5.4.1. Key driving factors, trends and opportunities
5.4.2. Market size and forecast, 2015-2026
5.5. Global Meningitis Vaccine Market, by Pneumococcal Meningitis, 2015-2026
5.5.1. Key driving factors, trends and opportunities
5.5.2. Market size and forecast, 2015-2026
5.6. Global Meningitis Vaccine Market, by Other types of Meningitis, 2015-2026
5.6.1. Key driving factors, trends and opportunities
5.6.2. Market size and forecast, 2015-2026

6. Global Meningitis Vaccine Market, by Vaccines
6.1. Global Meningitis Vaccine Market, Size and Forecast, 2015-2026
6.2. Global Meningitis Vaccine Market, by Polysaccharide Vaccines, 2015-2026
6.2.1. Key driving factors, trends and opportunities
6.2.2. Market size and forecast, 2015-2026
6.3. Global Meningitis Vaccine Market, by Conjugate Vaccines, 2015-2026
6.3.1. Key driving factors, trends and opportunities
6.3.2. Market size and forecast, 2015-2026
6.4. Global Meningitis Vaccine Market, by Combination Vaccines, 2015-2026
6.4.1. Key driving factors, trends and opportunities
6.4.2. Market size and forecast, 2015-2026

7. Global Meningitis Vaccine Market, by Region
7.1. Meningitis Vaccine Market Regional Analysis, 2015-2026
7.2. Global Meningitis Vaccine Market Revenue (USD Million) by Region, 2015-2026
7.3. North America Meningitis Vaccine Market, 2015-2026
7.3.1. North America Meningitis Vaccine Market Size and Forecast, 2015-2026
7.3.2. North America Meningitis Vaccine Market by Country, 2015-2026
7.3.2.1. U.S. Meningitis Vaccine Market, 2015-2026
7.3.2.2. Canada Meningitis Vaccine Market, 2015-2026
7.4. Europe Meningitis Vaccine Market, 2015-2026
7.4.1. Europe Meningitis Vaccine Market Size and Forecast, 2015-2026
7.4.2. Europe Meningitis Vaccine Market by Country, 2015-2026
7.4.2.1. Germany Meningitis Vaccine Market, 2015-2026
7.4.2.2. France Meningitis Vaccine Market, 2015-2026
7.4.2.3. Italy Meningitis Vaccine Market, 2015-2026
7.4.2.4. UK Meningitis Vaccine Market, 2015-2026
7.4.2.5. Spain Meningitis Vaccine Market, 2015-2026
7.4.2.6. Rest of Europe Meningitis Vaccine Market, 2015-2026
7.5. Asia Pacific Meningitis Vaccine Market, 2015-2026
7.5.1. Asia Pacific Meningitis Vaccine Market Size and Forecast, 2015-2026
7.5.2. Asia Pacific Meningitis Vaccine Market by Country, 2015-2026
7.5.2.1. Japan Meningitis Vaccine Market, 2015-2026
7.5.2.2. China Meningitis Vaccine Market, 2015-2026
7.5.2.3. India Meningitis Vaccine Market, 2015-2026
7.5.2.4. Rest of Asia Pacific Meningitis Vaccine Market, 2015-2026
7.6. South America Meningitis Vaccine Market, 2015-2026
7.6.1. South America Meningitis Vaccine Market Size and Forecast, 2015-2026
7.6.2. South America Meningitis Vaccine Market by Country, 2015-2026
7.6.2.1. Mexico Meningitis Vaccine Market, 2015-2026
7.6.2.2. Brazil Meningitis Vaccine Market, 2015-2026
7.6.2.3. Rest of South America Meningitis Vaccine Market, 2015-2026
7.7. Middle East & Africa Meningitis Vaccine Market, 2015-2026
7.7.1. Middle East & Africa Meningitis Vaccine Market Size and Forecast, 2015-2026
7.7.2. Middle East & Africa Meningitis Vaccine Market by Country, 2015-2026
7.7.2.1. Saudi Arabia Meningitis Vaccine Market, 2015-2026
7.7.2.2. South Africa Meningitis Vaccine Market, 2015-2026
7.7.2.3. Rest of Middle East & Africa Meningitis Vaccine Market, 2015-2026

8. Competitive Landscape
8.1. Introduction
8.2. Market Share Analysis/Top Player Positioning, 2019

9. Company Profiles
9.1. GlaxoSmithKline
9.1.1. Company Overview
9.1.2. Financial Overview
9.1.3. Product Benchmarking
9.1.4. Key Developments
9.2. Baxter International
9.2.1. Company Overview
9.2.2. Financial Overview
9.2.3. Product Benchmarking
9.2.4. Key Developments
9.3. Sanofi Pasteur
9.3.1. Company Overview
9.3.2. Financial Overview
9.3.3. Product Benchmarking
9.3.4. Key Developments
9.4. Merck
9.4.1. Company Overview
9.4.2. Financial Overview
9.4.3. Product Benchmarking
9.4.4. Key Developments
9.5. Pfizer
9.5.1. Company Overview
9.5.2. Financial Overview
9.5.3. Product Benchmarking
9.5.4. Key Developments
9.6. Serum Institute of India Pvt. Ltd.
9.6.1. Company Overview
9.6.2. Financial Overview
9.6.3. Product Benchmarking
9.6.4. Key Developments
9.7. Panacea Biotec
9.7.1. Company Overview
9.7.2. Financial Overview
9.7.3. Product Benchmarking
9.7.4. Key Developments
9.8. Johnson & Johnson
9.8.1. Company Overview
9.8.2. Financial Overview
9.8.3. Product Benchmarking
9.8.4. Key Developments
9.9. Astellas Pharma Inc.
9.9.1. Company Overview
9.9.2. Financial Overview
9.9.3. Product Benchmarking
9.9.4. Key Developments
9.10. Serum Institute of India Pvt. Ltd.
9.10.1. Company Overview
9.10.2. Financial Overview
9.10.3. Product Benchmarking
9.10.4. Key Developments

10. Key Insights

Content are not available

Choose License Type